Report Detail

Request for Sample of this report

Other Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2019-2024

  • RnM2881573
    • |
  • 05 February, 2019
    • |
  • Global
    • |
  • 150 Pages
    • |
  • LPI(LP Information)
    • |
  • Other

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.

Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
According to the research, the most potential market in the main countries of circulating tumor cells (CTCs) and cancer stem cells (CSCs) industry is China, determined by the rising level of medical care. Besides, South America, Asia-Pacific should also be focused by the investors. They are the potential consumers of circulating tumor cells (CTCs) and cancer stem cells (CSCs).
The CellSearch test is the only FDA-approved test for CTC assessment. For the moment, the products are not comprehensive, and technologies are not stable.
Morbidity and mortality rate of cancer is rising at a faster speed worldwide and thus prevention of cancer and cancer treatment is grabbing attention of cancer researchers globally. Stem cells and cell therapy have shown significant potential to treat cancer effectively.

According to this study, over the next five years the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market will register a 22.5% CAGR in terms of revenue, the global market size will reach US$ 21700 million by 2024, from US$ 6420 million in 2019. In particular, this report presents the global revenue market share of key companies in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by product type, application, key companies and key regions.

This study considers the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
CellSearch
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by identifying its various subsegments.
Focuses on the key global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size 2014-2024
        • 2.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size CAGR by Region
      • 2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Type
        • 2.2.1 CellSearch
        • 2.2.2 Others
      • 2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
        • 2.3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type (2014-2019)
      • 2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Application
        • 2.4.1 Breast Cancer Diagnosis and Treatment
        • 2.4.2 Prostate Cancer Diagnosis and Treatment
        • 2.4.3 Colorectal Cancer Diagnosis and Treatment
        • 2.4.4 Lung Cancer Diagnosis and Treatment
        • 2.4.5 Other Cancers Diagnosis and Treatment
      • 2.5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
        • 2.5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Application (2014-2019)

      3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Players

      • 3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Players
        • 3.1.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Players (2017-2019)
        • 3.1.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Market Share by Players (2017-2019)
      • 3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions

      • 4.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions
      • 4.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
      • 4.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
      • 4.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth
      • 4.5 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth

      5 Americas

      • 5.1 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries
      • 5.2 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
      • 5.3 Americas Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Countries
      • 6.2 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
      • 6.3 APAC Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries
      • 7.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
      • 7.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries
      • 8.2 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
      • 8.3 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast

      • 10.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast (2019-2024)
      • 10.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions
        • 10.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Type
      • 10.8 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecast by Application

      11 Key Players Analysis

      • 11.1 Janssen
        • 11.1.1 Company Details
        • 11.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Janssen News
      • 11.2 Qiagen
        • 11.2.1 Company Details
        • 11.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Qiagen News
      • 11.3 Advanced Cell Diagnostics
        • 11.3.1 Company Details
        • 11.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Advanced Cell Diagnostics News
      • 11.4 ApoCell
        • 11.4.1 Company Details
        • 11.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 ApoCell News
      • 11.5 Biofluidica
        • 11.5.1 Company Details
        • 11.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Biofluidica News
      • 11.6 Clearbridge Biomedics
        • 11.6.1 Company Details
        • 11.6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Clearbridge Biomedics News
      • 11.7 CytoTrack
        • 11.7.1 Company Details
        • 11.7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 CytoTrack News
      • 11.8 Celsee
        • 11.8.1 Company Details
        • 11.8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Celsee News
      • 11.9 Fluxion
        • 11.9.1 Company Details
        • 11.9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Fluxion News
      • 11.10 Gilupi
        • 11.10.1 Company Details
        • 11.10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offered
        • 11.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Gilupi News
      • 11.11 Cynvenio
      • 11.12 On-chip
      • 11.13 YZY Bio
      • 11.14 BioView
      • 11.15 Fluidigm
      • 11.16 Ikonisys
      • 11.17 AdnaGen
      • 11.18 IVDiagnostics
      • 11.19 Miltenyi Biotec
      • 11.20 ScreenCell
      • 11.21 Silicon Biosystems

      12 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) . Industry analysis & Market Report on Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is a syndicated market report, published as Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,660.00
      		$5,490.00
      		$7,320.00
      		2,829.18
      		4,243.77
      		5,658.36
      		3,407.46
      		5,111.19
      		6,814.92
      		558,845.40
      		838,268.10
      		1,117,690.80
      		308,904.00
      		463,356.00
      		617,808.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo